Onconetix Inc与Ocuvex经过评估后认为,双方各自独立发展的路径最符合利益相关者的最佳利益。
Onconetix Inc与Ocuvex经过评估后认为,双方各自独立发展的路径最符合利益相关者的最佳利益。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.